Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pretreatment with Stellate Ganglion Block Reduces the Incidence and Severity of Cardiac Surgery-Associated Acute Kidney Injury

NCT05652179 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05652179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05652179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pretreatment with Stellate Ganglion Block Reduces the Incidence and Severity of Cardiac Surgery-Associated Acute Kidney Injury
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2023
Completion date
December 30, 2023
Enrollment
396 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stellate ganglion block